A detailed history of Franklin Resources Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 2,241,354 shares of GILD stock, worth $202 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,241,354
Previous 1,824,975 22.82%
Holding current value
$202 Million
Previous $125 Million 50.04%
% of portfolio
0.05%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $27.7 Million - $35 Million
416,379 Added 22.82%
2,241,354 $188 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $5.89 Million - $6.8 Million
-93,282 Reduced 4.86%
1,824,975 $125 Million
Q1 2024

May 13, 2024

SELL
$71.58 - $87.29 $32.9 Million - $40.1 Million
-459,098 Reduced 19.31%
1,918,257 $141 Million
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $16.3 Million - $18.5 Million
-222,054 Reduced 8.54%
2,377,355 $193 Million
Q3 2023

Nov 13, 2023

SELL
$73.94 - $80.67 $28.4 Million - $31 Million
-384,325 Reduced 12.88%
2,599,409 $195 Million
Q2 2023

Aug 11, 2023

BUY
$76.01 - $86.7 $21.9 Million - $25 Million
288,030 Added 10.68%
2,983,734 $230 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $23.4 Million - $26.6 Million
-302,308 Reduced 10.08%
2,695,704 $224 Million
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $21 Million - $30.2 Million
337,058 Added 12.67%
2,998,012 $257 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $7.35 Million - $8.39 Million
123,405 Added 4.86%
2,660,954 $164 Million
Q2 2022

Aug 11, 2022

SELL
$57.72 - $65.01 $50.3 Million - $56.7 Million
-872,043 Reduced 25.58%
2,537,549 $157 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $36.4 Million - $45.7 Million
-629,313 Reduced 15.58%
3,409,592 $203 Million
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $58.5 Million - $66.4 Million
902,186 Added 28.76%
4,038,905 $293 Million
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $83.4 Million - $89.9 Million
-1,231,542 Reduced 28.19%
3,136,719 $219 Million
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $9.28 Million - $10.1 Million
146,187 Added 3.46%
4,368,261 $301 Million
Q1 2021

May 13, 2021

SELL
$60.0 - $68.46 $180 Million - $206 Million
-3,007,645 Reduced 41.6%
4,222,074 $273 Million
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $84.7 Million - $96.6 Million
-1,495,988 Reduced 17.14%
7,229,719 $421 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $98.3 Million - $124 Million
1,582,956 Added 22.16%
8,725,707 $551 Million
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $471 Million - $547 Million
-6,509,081 Reduced 47.68%
7,142,751 $545 Million
Q1 2020

May 13, 2020

SELL
$62.63 - $80.22 $111 Million - $142 Million
-1,774,281 Reduced 11.5%
13,651,832 $1.02 Billion
Q4 2019

Feb 12, 2020

SELL
$61.62 - $67.78 $54.5 Million - $59.9 Million
-884,177 Reduced 5.42%
15,426,113 $1 Billion
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $232 Million - $256 Million
3,716,878 Added 29.51%
16,310,290 $1.03 Billion
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $17.5 Million - $19.6 Million
282,679 Added 2.3%
12,593,412 $851 Million
Q1 2019

May 14, 2019

SELL
$62.53 - $70.05 $4.89 Million - $5.48 Million
-78,272 Reduced 0.63%
12,310,733 $800 Million
Q4 2018

Feb 12, 2019

SELL
$60.54 - $79.0 $9.69 Million - $12.6 Million
-160,028 Reduced 1.28%
12,389,005 $775 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $46.6 Million - $51.6 Million
-653,824 Reduced 4.95%
12,549,033 $969 Million
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $15.6 Million - $18.2 Million
-240,025 Reduced 1.79%
13,202,857 $935 Million
Q1 2018

May 10, 2018

SELL
$72.84 - $88.8 $29.7 Million - $36.3 Million
-408,296 Reduced 2.95%
13,442,882 $1.01 Billion
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $52 Million - $61 Million
-730,420 Reduced 5.01%
13,851,178 $992 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $1.05 Billion - $1.25 Billion
14,581,598
14,581,598 $1.18 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.